[Induction chemotherapy of non-Hodgkin malignant lymphomas. Results of a controlled trial comparing two quadruple associations (author's transl)]. 1978

M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde

Two types of chemotherapy have been compared in a randomized trial to treat non-Hodgkin malignant lymphomas. 66 patients were included in this study, but only 40 were evaluable after a histologic review of all cases. Treatment were an association of cyclophosphamide, vincristine, prednisone and doxorubicine or VM 26. Patients received only one induction chemotherapy course during 15--20 days. Results were evaluated immediately at the end of the course. Side-effects were mild. Efficacy was about the same with the two protocols: 35 patients out of 40 experienced a remission of more than 50% (among them 8 experienced a complete remission). These results are better than previous one obtained with cyclophosphamide, vincristine and prednisone only. It is concluded that this type of treatment is well tolerated, quickly efficient and useful before treating patients with radiotherapy or long-term chemotherapy.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1977, Sangre,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
May 1981, Revue medicale de Bruxelles,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1977, Sangre,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1977, Sangre,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
April 1980, Leber, Magen, Darm,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
May 1979, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1977, Sangre,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1978, Bulletin du cancer,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
October 1978, Casopis lekaru ceskych,
M Durand, and J Chauvergne, and G Hoerni-Simon, and C Meugé, and A De Mascarel, and P Richaud, and R Brunet, and B Hoerni, and C Lagarde
January 1978, Dermatologica,
Copied contents to your clipboard!